Adipsin as a novel prognostic biomarker for cardiovascular diseases

Creative Commons License

Askin L., Askin H. S., Abus S., HİDAYET Ş.

COR ET VASA, cilt.64, sa.1, ss.34-37, 2022 (ESCI) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 64 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.33678/cor.2021.086
  • Dergi Adı: COR ET VASA
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE
  • Sayfa Sayıları: ss.34-37
  • Anahtar Kelimeler: Adipsin, Atherosclerosis, Cardiovascular disease, C-REACTIVE PROTEIN, CORONARY-HEART-DISEASE, PROMOTING INFLAMMATION, MYOCARDIAL-INFARCTION, NATRIURETIC PEPTIDE, INSULIN-RESISTANCE, RISK-FACTORS, HYPERTENSION, ADIPONECTIN, CYCLOPHILIN
  • İnönü Üniversitesi Adresli: Evet

Özet

Increased vascular oxidative stress stimulates the secretion of adipokines from adipocytes. Many clinical studies have demonstrated that plasma adipsin levels are successful in predicting ischemic events. Increased adipsin levels are closely related to all-cause death and morbidity. Therefore, adipsin may be a new biomarker for atherosclerosis. In this review, we aimed to emphasize the association of adipsin with cardiovascular diseases (CVDs) and its beneficial role in the therapeutic field of CVDs.